17 Education & Technology Group, Inc. (NASDAQ:YQ) Q4 2024 Earnings Conference Call March 25, 2025 8:00 AM ET
Company Participants
Lara Zhao - IR Manager
Michael Chao Du - Director & CFO
Conference Call Participants
Operator
Good evening, and good morning ladies and gentlemen, and thank you for standing by for the 17EdTech's Fourth Quarter 2024 and Full Year Earnings Conference Call. At this time, all participants are in listen only mode. After the management's prepared remarks, there will be a question-and-answer session. As a reminder, today's conference call is being recorded.
I will now turn the meeting over to your host for today's call, Ms. Lara Zhao, 17EdTech's Invest Relations Manager. Please proceed, Lara.
Lara Zhao
Thank you, operator. Hello, everyone, and thank you for joining us today. Our earnings release was distributed earlier today and is available on our IR website.
Joining us today are Mr. Michael Du, Director and Chief Financial Officer, and myself, Investor Relations Manager. Michael will walk you through our latest business performance and strategies, and I will discuss our financial performance in more detail. After the prepared remarks, Michael will be available to answer your questions during the Q&A session.
Before we begin, I'd like to remind you that this conference call contains forward-looking statements as defined in Section 21E of the Securities Exchange Act of 1934 and the U.S. Private Security Litigation Reform Act of 1995. These forward-looking statements are based upon management's current expectations and current market and operating conditions, and relates to events that involve known and unknown risks, uncertainties, and other factors, all of which are difficult to predict and many of which are beyond the company's control. These risks may cause the company's actual results, performance, or achievements to differ materially. Further information regarding these and other risks, uncertainties and factors is included in the company's filings with the US
- Read more current YQ analysis and news
- View all earnings call transcripts